| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10743733 | Maturitas | 2008 | 5 Pages |
Abstract
We found no evidence of an elevated risk of stroke associated with the use of tibolone, although the low number of subjects using tibolone does not permit to rule out a small risk. The small elevated risk of stroke with estrogens or estrogens plus progestogen is consistent with that reported in randomised trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Christel Renoux, Sophie Dell'Aniello, Edeltraut Garbe, Samy Suissa,